Latest News

Walgreens Boots Alliance launches new GBP120 rapid COVID-19 for symptomless customers


Walgreens Boots Alliance Inc‘s (NASDAQ:WBA) UK division Boots is launching new COVID-19 testing services to ease pressure on the NHS and the government’s programme.

The pharmacy chain is launching a new GBP120 swab test that returns results on 12 minutes.

READ: Walgreens Boots Alliance reports low summer footfall for Boots UK

It is specifically aimed at those who don’t have symptoms and want “peace of mind”, the company said, and not at those who do have symptoms or believe they may have COVID-19, since it requires customers to attend stores.

The assay is produced by LumiraDx, a private UK-based company, and was accurate in 97% of cases in trials.

Another new service will start in 10 stores this week before rolling out to 50 Boots stores throughout November, with potential to extend to 200 stores over the coming months depending on demand and feedback.

Boots said this test is available as a private pre-flight testing service for customers who require a test before travelling abroad, also if they don’t have any symptoms to avoid infecting others.

“The service is already available in ten stores in total, which are located in London, Birmingham, Manchester, Edinburgh and Glasgow for customers travelling to UAE,” it stated.

However, the firm also noted that it is not currently approved as a pre-flight testing service, which requires a PCR test and for results to be processed via a registered lab.

For both services, patients can fill out a registration form and follow the instructions to book an appointment through the Boots online portal.

Shares in the wider company dipped 1% to US$37.60 in premarket trading.

Today’s Oil and Gas Update – IGAS Energy plc; Mosman Oil & Gas and more…

Previous article

FTSE 100 closes south of 5,800, Wall Street takes a beating as election nears

Next article

You may also like


Leave a reply

Your email address will not be published.

More in Latest News